Join TherapeutAix at the SMR Meeting ‘Innovative New Pharma & Biotech Partnerships’
Darcey Black, Translational Director at TherapeutAix, will be co-organising and attending the ‘Innovative New Pharma and Biotech Partnerships: How is…
International NASH Day 2022 – Enabling therapies for patients
Non-alcoholic steatohepatitis, or NASH, remains a disease with no approved therapeutics. And it’s been a tough area for drug development,…
TherapeutAix to attend Fraunhofer ‘Models of Lung Disease’ Seminar
TherapeutAix will be attending the 20th Fraunhofer Seminar ‘Models of Lung Disease’ on 22-24 June at the CRC Hannover in…
TherapeutAix to present at Extracellular Matrix Pharmacology Congress
TherapeutAix is attending and presenting at the Extracellular Matrix Pharmacology Congress 2022, on 23-25 June at the Tivoli Congress Centre…
Workshops reloaded
At TherapeutAix, we have a number of tools to support our clients. In addition to, for example, the MIRIADD approach…
